Literature DB >> 1765575

An open trial of fluoxetine in the treatment of posttraumatic stress disorder.

C J McDougle, S M Southwick, D S Charney, R L St James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1765575

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience Research.

Authors:  Vasiliki Michopoulos; Seth Davin Norrholm; Tanja Jovanovic
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

Review 2.  Post-traumatic stress disorder and serotonin: new directions for research and treatment.

Authors:  L L Davis; A Suris; M T Lambert; C Heimberg; F Petty
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 3.  SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Authors:  Gregory M Asnis; Shari R Kohn; Margaret Henderson; Nicole L Brown
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  D J Stein; J C Ipser; S Seedat
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

5.  Psychopharmacology of anxiety disorders.

Authors:  Giovanni B Cassano; Nicolò Baldini Rossi; Stefano Pini
Journal:  Dialogues Clin Neurosci       Date:  2002-09       Impact factor: 5.986
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.